Etoperidone
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Image:Etoperidone structure.svg | |
| Etoperidone
| |
| Systematic (IUPAC) name | |
| 2-[3-[4-(3-chlorophenyl)piperazin-1-yl] propyl]-4,5-diethyl-1,2,4-triazol-3-one | |
| Identifiers | |
| CAS number | |
| ATC code | N06 |
| PubChem | |
| Chemical data | |
| Formula | C19H28ClN5O |
| Mol. mass | 377.911 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Etoperidone (1-(3-Chlorophenyl)-4-(3-chloropropyl) piperazine HCI), an atypical antidepressant, is a 5-HT2 receptor antagonist[1] similar in molecular structure to trazodone. In the 1970's it was a popular drug used to impede the effects of LSD.
 | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |
